Furosemide Inhalation in Dyspnea of Mustard Gas Exposed Patients
to assess the efficacy of inhaled furosemide in mustard gas exposed patients with acute respiratory...
Brief Summary
Official Title: “Furosemide Inhalation in Dyspnea of Mustard Gas Exposed Patients: a Double-Blind Randomized Study”
to assess the efficacy of inhaled furosemide in mustard gas exposed patients with acute respiratory failure
- Study Type: Interventional
- Study Design: Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Supportive Care
Intervention(s) in this Clinical Trial
- Drug: furosemide
Outcome Measures for this Clinical Trial
Primary Measures
- effect of furosemid inhalation on dyspnea
Criteria for Participation in this Clinical Trial
Inclusion Criteria:
- Patients with a history of exposure to sulfur mustard with a complaint of dyspnea
Exclusion Criteria:
- A contraindication for furosemide use;
- An accompanying disease in which other drugs effective for dyspnea were used
Gender Eligibility for this Clinical Trial: Male
Minimum Age for this Clinical Trial: 32 Years
Maximum Age for this Clinical Trial: 83 Years
Clinical Trial Investigator Information
Lead Investigator: Baqiyatallah Medical Sciences University Other
Overall Clinical Trial Officials and Contacts
Mostafa Ghanei, MD Study Chair Research Center of Chemical Injuries, Baqiyatallah Medical Science University, Tehran, Iran
Additional Information
Information obtained from ClinicalTrials.gov on February 12, 2012
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00512811
Study ID Number: 121a25
ClinicalTrials.gov Identifier: NCT00512811
Health Authority: Iran: Ethics Committee
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is:
http://clinicaltrialsfeeds.org/clinical-trials/show/NCT00512811
